Null association between insulin-like growth factors, insulin-like growth factor-binding proteins, and prostate cancer in a prospective study.
Lacey
J V
JV
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20852, USA. jimlacey@nih.gov
Hsing
A W
AW
Fillmore
C M
CM
Hoffman
S
S
Helzlsouer
K J
KJ
Comstock
G W
GW
D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000032:analysis*; D016022:Case-Control Studies; D016001:Confidence Intervals; D006801:Humans; D015994:Incidence; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000032:analysis*; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D011336:Probability; D011446:Prospective Studies; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000453:epidemiology*; D012016:Reference Values; D018570:Risk Assessment; D012307:Risk Factors; D012680:Sensitivity and Specificity; D013002:Somatomedins / Q000032:analysis*
D014408:Biomarkers, Tumor; D018972:Insulin-Like Growth Factor Binding Protein 3; D013002:Somatomedins